Coronary Physiology Is Useful in Chronic Kidney Disease

Coronary physiology, FFR and iFR, has been shown safe to defer lesions and effective to save stents by different randomized studies and registries. However, patients with chronic kidney disease have not been thoroughly analyzed yet, which brings us to the question about what to do in the face of their negative evolution, when atherosclerosis develops faster, and stress tests are required before we would normally expect.

taller de imágenes y fisiología intracoronaria

This is a retrospective study including 439 patients. 319 (72.7%) presented conserved kidney function assessed with glomerular filtration (eGFR > 60 mL/min/1.73 m2,), and 120 showed evidence of chronic kidney disease (CKD) (glomerular filtration eGFR < 60 mL/min/1.73 m2).

251 patients with conserved kidney function were deferred with FFR (78,7%) and 78 with iFR (21,3%), while 94 CKD patients were deferred with FFR (78,3%) and 26 with iFR (21,7%).

Primary end point was a composite of all cause death, MI or unplanned revascularization. Secondary end point was all cause death, cardiac death, MI and unplanned revascularization. 

Patients with CKD were older, and presented more hypertension, diabetes, peripheral vascular disease and use of anticoagulation, but lower use of ASA. 

Read also: Tricuspid Regurgitation: Edge-to-Edge Treatment with PASCAL.

There were no differences in number of interrogated lesions or their location. The left anterior descending artery was the most involved. 

FFR was used 80% of times.

After 4 years, primary end point was higher in patients with CKD (25% vs. 14% p=0.01). Also, all-cause mortality (13.3% vs. 5.3%, p=0.006) and cardiovascular mortality (5.8% vs. 1.3% p=0.01) were higher. Unplanned revascularization was also higher, though not significantly. There were no differences in MI or target vessel related MI. 

Read also: Progress-CTO Score: A Key New Tool to Plan CTO.

Patients with 4 or 5 stage CKD presented more events vs. patients with conserved kidney function.

Evolution was analyzed according to lesion assessment strategy and there were no differences between FFR and iFR.

Conclusion

Patients with CKD and deferred coronary lesions after pressure-wire evaluation develop more events in the long term compared against patients presenting conserved kidney function. However, this increased number of events in CDK patients was rarely related to the deferred vessel, which suggests an epiphenomenon of intrinsically higher cardiovascular risk in CKD patients.

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Safety of coronary revascularization deferral based on fractional flow reserve and instantaneous wave-free ratio in patients with chronic kidney disease.

Reference: Alejandro Travieso, et al. Cardiol J 2022, 29, 4: 553–562.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...